Sun, Sep 14, 2014, 10:08 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • makea_bayn makea_bayn Dec 23, 2013 7:34 AM Flag

    Pricing and Revenue Information Excerpt from May 13th Article AVG 7150.00

    Approximately 10% of diabetics will develop Diabetic Macular Edema. The proposed price for Iluvien in Europe will be somewhere between $5,500 to $8,800. For the purpose of this article I will use the average, which is $7150.

    Austria:
    Has approximately 400,000 diabetics.
    400,000 * 0.10 = 40,000 potential patients
    40,000 * $7150 = $286,000,000 sales

    Portugal:
    Has approximately 900,000 diabetics
    900,000 * 0.10 = 90,000 potential patients
    90,000 * $7150 = $643,500,000 sales

    France:
    Has approximately 3,945,753 diabetics
    3,945,753 * 0.10 = 394,575 potential patients
    394,575 * $7150 = $2,821,211,250 sales

    Spain:
    Has approximately 3,635,946 diabetics
    3,635,946 * 0.10 = 363,594 potential patients
    363,594 * $7150 = $2,599,697,100 sales

    Germany:
    Has approximately 7,372,226 diabetics
    7,372,226 * 0.10 = 737,222 potential patients
    737,222 * $7150 = $5,271,137,300 sales

    United Kingdom:
    I will use a cost of $5500 for the U.K. since it is most likely to be lower in the U.K.
    Has approximately 3,636,375 diabetics
    3,636,375 * 0.10 = 363,637 potential patients
    363,637 * $5500 = $2,000,003,500 sales

    Therefore, based on the above projections, presuming that Alimera will get 1.6 billion in revenue, the share price target of Alimera should be way north of $10.00. Analysts will be coming out with their price per share targets well above this prediction very soon. Best to be in early for big profits.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALIM
5.93-0.21(-3.42%)Sep 12 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT
Darden Restaurants, Inc.
NYSEFri, Sep 12, 2014 4:03 PM EDT